Clinical trial
PLASOMA Efficacy & Technology Health (PETH) Study: A Post-market Randomised Controlled Efficacy Study of PLASOMA on Wound Healing in Chronic Venous Leg Ulcers
NCT04922463 is registered in ClinicalTrials.gov with Plasmacure as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- PLASOMA Efficacy & Technology Health (PETH) Study: A Post-market Randomised Controlled Efficacy Study of PLASOMA on Wound Healing in Chronic Venous Leg Ulcers
- Lead sponsor
- Plasmacure
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- June 1, 2021
- Completion date
- April 20, 2023
- Enrollment
- 46 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
venous leg ulcer